KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Treasury Shares (2016 - 2025)

Inovio Pharmaceuticals' Treasury Shares history spans 11 years, with the latest figure at $46828.0 for Q3 2025.

  • For Q3 2025, Treasury Shares fell 73.44% year-over-year to $46828.0; the TTM value through Sep 2025 reached $46828.0, down 73.44%, while the annual FY2024 figure was $337911.0, 22.97% up from the prior year.
  • Treasury Shares for Q3 2025 was $46828.0 at Inovio Pharmaceuticals, down from $47314.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $3.5 million in Q1 2022 and bottomed at $22500.0 in Q3 2023.
  • The 5-year median for Treasury Shares is $188804.0 (2024), against an average of $916432.4.
  • The largest annual shift saw Treasury Shares plummeted 95.55% in 2022 before it skyrocketed 683.46% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $2.4 million in 2021, then crashed by 91.3% to $212964.0 in 2022, then rose by 29.03% to $274794.0 in 2023, then rose by 22.97% to $337911.0 in 2024, then plummeted by 86.14% to $46828.0 in 2025.
  • Per Business Quant, the three most recent readings for INO's Treasury Shares are $46828.0 (Q3 2025), $47314.0 (Q2 2025), and $83800.0 (Q1 2025).